Find Expert Doctors on Cholangiocarcinoma1,191 top medical experts on Cholangiocarcinoma across 47 countries and 41 U.S. states, including 1,130 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.
- Cholangiocarcinoma: A malignant tumor arising from the epithelium of the bile ducts.
- Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
- Broader Categories (#Experts): Adenocarcinoma (5,212) and Narrower Categories: Klatskin Tumor (2,028).
- Clinical Trials
: at least 600 including 45 Active, 186 Completed, 170 Recruiting - Synonyms: Cholangiocellular Carcinoma
- Gores, Gregory J Gastroenterology
Division of Gastroenterology, Mayo Clinic, Rochester, MN, USA. Top HospitalSubjects: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangitis, Sclerosing; Liver Neoplasms; Liver TransplantationCategories: Pathology; Metabolism; Genetics; Therapy; Diagnosis; Drug Therapy - Pawlik, Timothy M Surgical Oncology Department of Surgery, Ohio State University Wexner Medical Center, Columbus, Ohio, USA. Top HospitalMedical school: Tufts University School of Medicine (MD, 1995)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 82.3/100Subjects: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Hepatectomy; Liver Neoplasms; Neoplasm Recurrence, LocalCategories: Surgery; Pathology; Mortality; Therapy; Genetics; Diagnosis
- Zhu, Andrew X Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA; Jiahui International Cancer Center, Jiahui Health, Shanghai, China. Top HospitalSubjects: Bile Duct Neoplasms; Liver Neoplasms; Carcinoma, Hepatocellular; Isocitrate Dehydrogenase; Bile Ducts, IntrahepaticCategories: Genetics; Radiotherapy; Drug Therapy; Pathology; Therapy; Therapeutic Use
- Borad, Mitesh J Hematology & Oncology Department Medical Oncology, Mayo Clinic, Phoenix, AZ. Top HospitalMedical school: Rowan University School of Osteopathic Medicine (MD, 2000)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 64/100Disclosed payments in 2021 from 8 biomedical companies, totalling $4,339.68, including $2,005.53 from F. Hoffmann-La Roche AGSubjects: Bile Duct Neoplasms; Receptor, Fibroblast Growth Factor, Type 2; Pyrimidines; Bile Ducts, Intrahepatic; Antineoplastic AgentsCategories: Drug Therapy; Genetics; Administration & Dosage; Metabolism; Therapeutic Use; Antagonists & Inhibitors
- Roberts, Lewis R Ophthalmology Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN. Top HospitalRelevant US NIH Grant Funding: $4,932,702 over the last 5 yearsSubjects: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Liver Neoplasms; Isocitrate Dehydrogenase; Receptor, Fibroblast Growth Factor, Type 2Categories: Genetics; Metabolism; Pathology; Drug Therapy; Mortality; Pharmacology
- Javle, Milind M Hematology & Oncology Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.Medical school: Other (MD, 1992)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 68/100Disclosed payments in 2021 from 42 biomedical companies, totalling $66,446.27, including $27,315.77 from Incyte CorporationSubjects: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Pyrimidines; Antineoplastic Agents; Liver NeoplasmsCategories: Genetics; Drug Therapy; Therapeutic Use; Radiotherapy; Administration & Dosage; Surgery
- Poultsides, George A Surgery Department of Surgery, Stanford University, Stanford, California, USA. Top HospitalDisclosed payments from biomedical company (CONMED Corporation) in 2021 for $49.78Subjects: Bile Duct Neoplasms; Hepatectomy; Bile Ducts, Intrahepatic; Neoplasm Recurrence, Local; Lymph Node ExcisionCategories: Surgery; Mortality; Pathology; Therapy; Blood; Methods
- Heimbach, Julie K Transplant Surgery Divison of Transplant Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA. Top HospitalPhysician Highly CitedSubjects: Bile Duct Neoplasms; Liver Transplantation; Bile Ducts, Intrahepatic; Biopsy, Fine-Needle; ChemoradiotherapyCategories: Therapy; Surgery; Pathology; Diagnosis; Epidemiology; Therapeutic Use
- Ferrone, Cristina R Surgical Oncology Massachusetts General Hospital, Boston, MA. Top HospitalMedical school: Washington University School of Medicine (MD, 1997)Medicare AcceptedDisclosed payments in 2021 from 3 biomedical companies, totalling $2,069.71, including $1,879.5 from AstraZeneca Pharmaceuticals LPSubjects: Bile Duct Neoplasms; Liver Neoplasms; Isocitrate Dehydrogenase; Bile Ducts, Intrahepatic; Biomarkers, TumorCategories: Genetics; Surgery; Mortality; Pathology; Radiotherapy; Metabolism
- Aldrighetti, Luca A Department of Surgery, Ospedale San Raffaele, Milan, Italy.Subjects: Bile Duct Neoplasms; Hepatectomy; Bile Ducts, Intrahepatic; Neoplasm Recurrence, Local; Liver NeoplasmsCategories: Surgery; Pathology; Mortality; Methods; Blood; Epidemiology
- Jarnagin, William R Surgery Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. . Top HospitalDisclosed payments from biomedical company (FUJIFILM Healthcare Americas Corporation) in 2021 for $1,050Subjects: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Liver Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, HepatocellularCategories: Pathology; Surgery; Genetics; Drug Therapy; Diagnostic Imaging; Metabolism
- Andersen, Jesper B Biotech Research and Innovation Centre BRIC, Department of Health and Medical Sciences, University of Copenhagen, Copenhagen N, Denmark.Subjects: Bile Duct Neoplasms; Liver Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Antineoplastic AgentsCategories: Genetics; Metabolism; Pathology; Drug Therapy; Pharmacology; Therapeutic Use
- Khan, Shahid A Liver Unit, Division of Digestive Diseases, Imperial College London and Imperial College Healthcare NHS Trust, London, UK. Electronic address: .Subjects: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Liver; Bile; Bile Ducts, ExtrahepaticCategories: Metabolism; Epidemiology; Pathology; Therapy; Diagnosis; Drug Therapy
- Bauer, Todd W Surgical Oncology Department of Surgery, University of Virginia, Charlottesville, Virginia, USA. Top HospitalMedical school: Perelman School of Med at the University of Pennsylvania (MD, 1995)Medicare AcceptedDisclosed payments in 2021 from 6 biomedical companies, totalling $2,068.93, including $2,068.93 from Boehringer Ingelheim International GmbHSubjects: Bile Duct Neoplasms; Hepatectomy; Bile Ducts, Intrahepatic; Neoplasm Recurrence, Local; Lymph Node ExcisionCategories: Surgery; Pathology; Mortality; Blood; Therapy; Genetics
- Rizvi, Sumera H Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Top HospitalSubjects: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Molecular Targeted Therapy; Cholangitis, Sclerosing; Adaptor Proteins, Signal TransducingCategories: Metabolism; Therapy; Drug Therapy; Diagnosis; Physiology; Genetics
- Shroff, Rachna T Hematology & Oncology Division of Hematology and Oncology, University of Arizona Cancer Center, Tucson, AZ, USA. Top HospitalDisclosed payments in 2021 from 25 biomedical companies, totalling $47,852.08, including $13,211.43 from Servier Pharmaceuticals LLCSubjects: Bile Duct Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Glycine; MutationCategories: Drug Therapy; Genetics; Administration & Dosage; Metabolism; Radiotherapy; Mortality
- Goyal, Lipika Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Top HospitalSubjects: Bile Duct Neoplasms; Antineoplastic Agents; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 2; Isocitrate DehydrogenaseCategories: Genetics; Drug Therapy; Therapeutic Use; Administration & Dosage; Radiotherapy; Antagonists & Inhibitors
- Alvaro, Domenico Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.Subjects: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Liver Neoplasms; Biomarkers, Tumor; Cholangitis, SclerosingCategories: Pathology; Metabolism; Drug Therapy; Genetics; Diagnosis; Etiology
- Hong, Theodore S Radiation Oncology Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA. Top HospitalPhysician Clinical TrialMedical school: University of Connecticut School of Medicine (MD, 2000)Medicare AcceptedDisclosed payments in 2021 from 2 biomedical companies, totalling $4,700, including $3,200 from Novocure Inc.Subjects: Bile Duct Neoplasms; Liver Neoplasms; Carcinoma, Hepatocellular; Proton Therapy; Isocitrate DehydrogenaseCategories: Radiotherapy; Genetics; Diagnostic Imaging; Immunology; Blood; Methods
These expert listings are
for individual use without a fee. Biotechs,
Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and
other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards,
and consulting. Please contact
us for licensing, customized queries, feedback and questions.
Note:
- Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.